Last reviewed · How we verify
NCT04950049
The Effect of Dilution and Prolonged Injection Time on Dexamethasone-induced Perineal Irritation
NA trial testing Dexamethasone in Adverse Effect in 200 participants. Status unknown.
31 August 2021
Quick facts
| Lead sponsor | General Hospital of Ningxia Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 200 |
| Start date | 15 July 2021 |
| Primary completion | 31 August 2021 |
| Estimated completion | 31 August 2021 |
Drugs / interventions tested
- Dexamethasone (dexamethasone) — full drug profile →
- Diluted dexamethasone 5ml
- Diluted dexamethasone 10ml
- Diluted dexamethasone 20ml
Conditions studied
- Adverse Effect — all drugs for Adverse Effect →
Sponsor
General Hospital of Ningxia Medical University
Who can join
Adults 18 to 65, any sex, with Adverse Effect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the efficacy of dilution with glucose and prolonged injection time on dexamethasone 21-phosphate induced perineal irritation (include pian and pruritus).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of dilution with glucose and prolonged injection time on dexamethasone-induced perineal irritation - A randomized controlled trial.
Zhang Y, Liang H, Huang L, Zheng J, et al · · 2022 · PMID 36237832 · DOI 10.1515/med-2022-0556
Verify or expand the search:
- PubMed search for NCT04950049
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexamethasone
Trials testing the same drug.
- NCT07543458 — Therapeutics for Moderate and Severe Dengue · Phase 3 · not yet recruiting
- NCT07175415 — HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological · Phase 1, PHASE2 · not yet recruiting
- NCT07513129 — A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients · Phase 1 · not yet recruiting
- NCT07444710 — Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) · Phase 1 · not yet recruiting
- NCT07387926 — Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+ · Phase 1, PHASE2 · not yet recruiting
Other recruiting trials for Adverse Effect
Currently open trials in the same condition.
- NCT06570629 — Addressing Unintentional Leakage When Using Nasal CPAP - Study B · NA · recruiting
- NCT06570616 — Addressing Unintentional Leakage When Using Nasal CPAP - Study A · NA · recruiting
- NCT06467045 — Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging · recruiting
Other General Hospital of Ningxia Medical University trials
Trials by the same sponsor.
- NCT07496086 — External Oblique Intercostal Block Versus Transversus Abdominis Plane Combined With Rectus Sheath Block on Postoperative · NA · recruiting
- NCT07396545 — External Oblique Intercostal Block Versus Erector Spinae Plane Block on Postoperative Pain in Laparoscopic Radical Gastr · NA · recruiting
- NCT07366853 — Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach · NA · not yet recruiting
- NCT07239531 — The Application of Intermittent Training in Clinical Skills Simulation Training · NA · not yet recruiting
- NCT07248683 — Application of Intermittent Training in Radial Artery Puncture and Catheterization Skills Under Ultrasound-Guided Line G · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04950049 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by General Hospital of Ningxia Medical University
- Last refreshed: 6 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04950049.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing